Skip to content

Effective dose of fospropofol disodium for induction of anesthesia in adults patients : A prospective exploratory study

Effective dose of fospropofol disodium for induction of anesthesia in adults patients : A dose-finding study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111525
Enrollment
Unknown
Registered
2025-11-01
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental Group:The patients were divided into two groups based on age: the adult group (<65 years old) and the elderly group (=65 years old). The test drug is disodium phosphopropofol for injectio

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-65 years old (inclusive of 18 years old but exclusive of 65 years old) or 65-80 years old (inclusive of 65 years old and 80 years old), American Society of Anesthesiology (ASA) physical constitution classification I-II; 2. Patients who need tracheal intubation for elective general anesthesia surgery; 3. Operation time >= 30 minutes; 4. body mass index (BMI) = 30kg/m ²; 5. The serum alkaline phosphatase level (ALP) is normal

Exclusion criteria

Exclusion criteria: Those with any of the following circumstances will not be considered as selected cases: 1.Patients with ASA grade III or above; 2. Patients with hypertension and unsatisfactory blood pressure control (systolic blood pressure >= 180mmHg or diastolic blood pressure >=100mmHg); 3. Patients with expected difficult airways or those requiring double-lumen tracheal intubation; 4. Patients who have successfully undergone two or more tracheal intubations during induction; 5. Patients who are obese (BMI>=30), underweight (BMI =100kg; 6. Patients with a history of severe asthma, allergic diseases and severe drug allergies; 7. Patients who have been using sedative-hypnotic drugs and anti-anxiety and anti-depression drugs for a long time; 8. Pregnant and lactating patients.

Design outcomes

Primary

MeasureTime frame
ED 50 and ED95 of inhibiting hemodynamic response to tracheal intubation during induction of general anesthesia;

Secondary

MeasureTime frame
Time of loss of consciousness;

Countries

China

Contacts

Public ContactZhiyu Geng

Department of anesthesiology, Peking University First Hospital

gengzhiyu2013@163.com+86 10 8357 5085

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026